Daniela Ferreira-Santos

Dr. Daniela Ferreira-Santos

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
DFDaniela Ferreira-Santos
Daniela Ferreira-Santos
PAPedro Amorim
Pedro Amorim
TMTiago Silva Martins
Tiago Silva Martins
Matilde Monteiro-SoaresMatilde Monteiro-Soares
Matilde Monteiro-Soares
Pedro PereiraPedro Pereira
Pedro Pereira
Background: American Academy of Sleep Medicine guidelines suggest that clinical prediction algorithms can be used to screen patients with obstructive sleep apnea (OSA) without replacing polysomnography, the gold standard. Objective: We aimed to identify, gather, and analyze existing machine learning approaches that are being used for disease screening in adult patients with suspected OSA. Methods: We searched the MEDLINE, Scopus, and ISI Web of Knowledge databases to evaluate the validity of different machine learning techniques, with polysomnography as the gold standard outcome measure and used the Prediction Model Risk of Bias Assessment Tool (Kleijnen Systematic Reviews Ltd) to assess risk of bias and applicability of each included study. Results: Our search retrieved 5479 articles, of which 63 (1.15%) articles were included. We found 23 studies performing diagnostic model development alone, 26 with added internal validation, and 14 applying the clinical prediction algorithm to an independent sample (although not all reporting the most common discrimination metrics, sensitivity or specificity). Logistic regression was applied in 35 studies, linear regression in 16, support vector machine in 9, neural networks in 8, decision trees in 6, and Bayesian networks in 4. Random forest, discriminant analysis, classification and regression tree, and nomogram were each performed in 2 studies, whereas Pearson correlation, adaptive neuro-fuzzy inference system, artificial immune recognition system, genetic algorithm, supersparse linear integer models, and k-nearest neighbors algorithm were each performed in 1 study. The best area under the receiver operating curve was 0.98 (0.96-0.99) for age, waist circumference, Epworth Somnolence Scale score, and oxygen saturation as predictors in a logistic regression. Conclusions: Although high values were obtained, they still lacked external validation results in large cohorts and a standard OSA criteria definition. Trial Registration: PROSPERO CRD42021221339; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=221339

26 July 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MDMiguel Duarte
Miguel Duarte
Pedro PereiraPedro Pereira
Pedro Pereira
DFDaniela Ferreira-Santos
Daniela Ferreira-Santos
Background: Digital clinical tools are a new technology that can be used in the screening or diagnosis of obstructive sleep apnea (OSA), notwithstanding the crucial role of polysomnography, the gold standard. Objective: This study aimed to identify, gather, and analyze the most accurate digital tools and smartphone-based health platforms used for OSA screening or diagnosis in the adult population. Methods: We performed a comprehensive literature search of PubMed, Scopus, and Web of Science databases for studies evaluating the validity of digital tools in OSA screening or diagnosis until November 2022. The risk of bias was assessed using the Joanna Briggs Institute critical appraisal tool for diagnostic test accuracy studies. The sensitivity, specificity, and area under the curve (AUC) were used as discrimination measures. Results: We retrieved 1714 articles, 41 (2.39%) of which were included in the study. From these 41 articles, we found 7 (17%) smartphone-based tools, 10 (24%) wearables, 11 (27%) bed or mattress sensors, 5 (12%) nasal airflow devices, and 8 (20%) other sensors that did not fit the previous categories. Only 8 (20%) of the 41 studies performed external validation of the developed tool. Of these, the highest reported values for AUC, sensitivity, and specificity were 0.99, 96%, and 92%, respectively, for a clinical cutoff of apnea-hypopnea index (AHI)≥30. These values correspond to a noncontact audio recorder that records sleep sounds, which are then analyzed by a deep learning technique that automatically detects sleep apnea events, calculates the AHI, and identifies OSA. Looking at the studies that only internally validated their models, the work that reported the highest accuracy measures showed AUC, sensitivity, and specificity values of 1.00, 100%, and 96%, respectively, for a clinical cutoff AHI≥30. It uses the Sonomat—a foam mattress that, aside from recording breath sounds, has pressure sensors that generate voltage when deformed, thus detecting respiratory movements, and uses it to classify OSA events. Conclusions: These clinical tools presented promising results with high discrimination measures (best results reached AUC>0.99). However, there is still a need for quality studies comparing the developed tools with the gold standard and validating them in external populations and other environments before they can be used in clinical settings. Trial Registration: PROSPERO CRD42023387748; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=387748

1 September 2018 in Artificial Intelligence in Medicine
Verified
Journal Article
Open access
Pedro PereiraPedro Pereira
Pedro Pereira
DFDaniela Ferreira-Santos
Daniela Ferreira-Santos
ASAna Silva
Ana Silva
Jorge J. PolóniaJorge J. Polónia
Jorge J. Polónia
IRInês Ribeiro-Vaz
Inês Ribeiro-Vaz
In pharmacovigilance, reported cases are considered suspected adverse drug reactions (ADR). Health authorities have thus adopted structured causality assessment methods, allowing the evaluation of the likelihood that a drug was the causal agent of an adverse reaction. The aim of this work was to develop and validate a new causality assessment support system used in a regional pharmacovigilance centre. A Bayesian network was developed, for which the structure was defined by experts while the parameters were learnt from 593 completely filled ADR reports evaluated by the Portuguese Northern Pharmacovigilance Centre medical expert between 2000 and 2012. Precision, recall and time to causality assessment (TTA) was evaluated, according to the WHO causality assessment guidelines, in a retrospective cohort of 466 reports (April-September 2014) and a prospective cohort of 1041 reports (January-December 2015). Additionally, a simplified assessment matrix was derived from the model, enabling its preliminary direct use by notifiers. Results show that the network was able to easily identify the higher levels of causality (recall above 80%), although struggling to assess reports with a lower level of causality. Nonetheless, the median (Q1:Q3) TTA was 4 (2:8) days using the network and 8 (5:14) days using global introspection, meaning the network allowed a faster time to assessment, which has a procedural deadline of 30 days, improving daily activities in the centre. The matrix expressed similar validity, allowing an immediate feedback to the notifiers, which may result in better future engagement of patients and health professionals in the pharmacovigilance system.

30 May 2023 in Pulmonology
Verified
Journal Article
Open access
DFDaniela Ferreira-Santos
Daniela Ferreira-Santos
PRP. Pereira Rodrigues
P. Pereira Rodrigues
Obstructive sleep apnea (OSA) is a prevalent sleep condition which is very heterogeneous although not formally characterized as such, resulting in missed or delayed diagnosis. Cluster analysis has been used in different clinical domains, particularly within sleep disorders. We aim to understand OSA heterogeneity and provide a variety of cluster visualizations to communicate the information clearly and efficiently. We applied an extension of k-means to be used in categorical variables: k-modes, to identify OSA patients' groups, based on demographic, physical examination, clinical history, and comorbidities characterization variables (n = 40) obtained from a derivation and validation cohorts (211 and 53, respectively) from the northern region of Portugal. Missing values were imputed with k-nearest neighbours (k-NN) and a chi-square test was held for feature selection. Thirteen variables were inserted in phenotypes, resulting in the following three clusters: Cluster 1, middle-aged males reporting witnessed apneas and high alcohol consumption before sleep; Cluster 2, middle-aged women with increased neck circumference (NC), non-repairing sleep and morning headaches; and Cluster 3, obese elderly males with increased NC, witnessed apneas and alcohol consumption. Patients from the validation cohort assigned to different clusters showed similar proportions when compared with the derivation cohort, for mild (C1: 56 vs 75%, P = 0.230; C2: 61 vs 75%, P = 0.128; C3: 45 vs 48%, P = 0.831), moderate (C1: 24 vs 25%; C2: 20 vs 25%; C3: 25 vs 19%) and severe (C1: 20 vs 0%; C2: 18 vs 0%; C3: 29 vs 33%) levels. Therefore, the allocation supported the validation of the obtained clusters. Our findings suggest different OSA patients' groups, creating the need to rethink these patients' stereotypical baseline characteristics.

16 September 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
DFDaniela Ferreira-Santos
Daniela Ferreira-Santos
PMPriscila Maranhão
Priscila Maranhão
Matilde Monteiro-SoaresMatilde Monteiro-Soares
Matilde Monteiro-Soares
Objectives Our research question was: what are the most frequent baseline clinical characteristics in adult patients with COVID-19? Our major aim was to identify common baseline clinical features that could help recognise adult patients at high risk of having COVID-19. Design We conducted a scoping review of all the evidence available at LitCovid, until 23 March 2020. Setting Studies conducted in any setting and any country were included. Participants Studies had to report the prevalence of sociodemographic characteristics, symptoms and comorbidities specifically in adults with a diagnosis of infection by SARS-CoV-2. Results In total, 1572 publications were published on LitCovid. We have included 56 articles in our analysis, with 89% conducted in China and 75% containing inpatients. Three studies were conducted in North America and one in Europe. Participants’ age ranged from 28 to 70 years, with balanced gender distribution. The proportion of asymptomatic cases were from 2% to 79%. The most common reported symptoms were fever (4%–99%), cough (4%–92%), dyspnoea/shortness of breath (1%–90%), fatigue (4%–89%), myalgia (3%–65%) and pharyngalgia (2%–61%), while regarding comorbidities, we found cardiovascular disease (1%–40%), hypertension (0%–40%) and cerebrovascular disease (1%–40%). Such heterogeneity impaired the conduction of meta-analysis. Conclusions The infection by COVID-19 seems to affect people in a very diverse manner and with different characteristics. With the available data, it is not possible to clearly identify those at higher risk of being infected with this condition. Furthermore, the evidence from countries other than China is, at the moment, too scarce.

13 April 2018 in International Journal of Data Science and Analytics
Verified
Journal Article
Open access
PDF file
DFDaniela Ferreira-Santos
Daniela Ferreira-Santos
Pedro PereiraPedro Pereira
Pedro Pereira
In obstructive sleep apnea, respiratory effort is maintained but ventilation decreases/disappears due to upper-airway partial/total occlusion. This condition affects about 4% of men and 2% of women worldwide. This study aimed to define an auxiliary diagnostic method that can support the decision to perform polysomnography, based on risk and diagnostic factors. Our sample performed polysomnography between January and May 2015. Two Bayesian classifiers were used to build the models: Naïve Bayes and Tree Augmented Naïve Bayes, using 38 variables identified by literature review or just a selection of 6. Area under the ROC curve, sensitivity, specificity and predictive values were evaluated using leave-one-out and cross-validation techniques. From a total of 241 patients, only 194 fulfilled the inclusion criteria, 123 (63%) were male, with a mean age of 58 years, 66 (34%) patients had a normal result and 128 (66%) a diagnosis of obstructive sleep apnea. The cross-validated AUCs for each model were: NB38: 69.2%; TAN38: 69.0%; NB6: 74.6% and TAN6: 63.6%. Regarding risk matrix, female gender presented a starting rate of 8%, comparing to 20% in male gender, almost 3 times higher. The high (34%) proportion of normal results confirms the need for a pre-evaluation prior to polysomnography, making the search for a validated model to screen patients with suspicion of obstructive sleep apnea essential, especially at primary care level.